UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000030208
Receipt No. R000034505
Scientific Title Effect of canagliflozin on the disposition index, a marker of pancreatic beta-cell function, in type 2 diabetic patients: a randomized controlled study
Date of disclosure of the study information 2018/03/28
Last modified on 2020/08/07 16:39:23

No. Disposal Last modified on Item of update
1 Insert 2017/12/01 10:56:21
2 Update 2018/01/31 11:40:29 Narrative objectives1
Narrative objectives1
Primary outcomes
Primary outcomes
3 Update 2018/01/31 11:51:53 Interventions/Control_1
Interventions/Control_1
Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
Key exclusion criteria
4 Update 2018/01/31 11:53:45 Date of disclosure of the study information
5 Update 2018/01/31 11:55:43 Date of protocol fixation
Anticipated trial start date
6 Update 2018/02/28 14:00:32 Narrative objectives1
Narrative objectives1
Primary outcomes
Key secondary outcomes
Key secondary outcomes
7 Update 2018/02/28 14:11:26 Interventions/Control_1
Interventions/Control_1
Interventions/Control_2
Key inclusion criteria
Key exclusion criteria
8 Update 2018/02/28 14:18:18 Date of disclosure of the study information
9 Update 2018/02/28 14:20:02 Date of protocol fixation
Anticipated trial start date
10 Update 2018/02/28 14:40:27 Public title
Acronym
11 Update 2018/02/28 16:50:42 Key exclusion criteria
12 Update 2018/03/15 17:03:24 Date of disclosure of the study information
13 Update 2018/03/15 17:04:52 Anticipated trial start date
14 Update 2018/03/22 11:41:38 Date of disclosure of the study information
15 Update 2018/03/22 11:42:22 Anticipated trial start date
16 Update 2018/04/03 10:05:26 Recruitment status
17 Update 2018/09/03 16:36:33 Recruitment status
18 Update 2019/05/09 09:09:52 Date of IRB
Last follow-up date
Other related information
19 Update 2020/08/07 16:39:23 Recruitment status


Contact us.